BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14716255)

  • 1. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
    Redding SW; Dahiya MC; Kirkpatrick WR; Coco BJ; Patterson TF; Fothergill AW; Rinaldi MG; Thomas CR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jan; 97(1):47-52. PubMed ID: 14716255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
    Redding SW; Bailey CW; Lopez-Ribot JL; Kirkpatrick WR; Fothergill AW; Rinaldi MG; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):659-62. PubMed ID: 11402278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
    Redding SW; Kirkpatrick WR; Coco BJ; Sadkowski L; Fothergill AW; Rinaldi MG; Eng TY; Patterson TF
    J Clin Microbiol; 2002 May; 40(5):1879-81. PubMed ID: 11980984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
    Redding SW; Kirkpatrick WR; Dib O; Fothergill AW; Rinaldi MG; Patterson TF
    Spec Care Dentist; 2000; 20(5):178-81. PubMed ID: 11203894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
    Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.
    Arikan S; Akova M; Hayran M; Ozdemir O; Erman M; Gür D; Unal S
    Clin Infect Dis; 1998 Apr; 26(4):903-8. PubMed ID: 9564473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal Candidiasis in Palliative Care Patients in Denmark.
    Astvad K; Johansen HK; Høiby N; Steptoe P; Ishøy T
    J Palliat Med; 2015 Nov; 18(11):940-4. PubMed ID: 26270132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oropharyngeal candidiasis in the era of antiretroviral therapy.
    Thompson GR; Patel PK; Kirkpatrick WR; Westbrook SD; Berg D; Erlandsen J; Redding SW; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):488-95. PubMed ID: 20156694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation.
    Redding SW; Kirkpatrick WR; Saville S; Coco BJ; White W; Fothergill A; Rinaldi M; Eng T; Patterson TF; Lopez-Ribot J
    J Clin Microbiol; 2003 Feb; 41(2):619-22. PubMed ID: 12574256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
    Dahiya MC; Redding SW; Dahiya RS; Eng TY; Kirkpatrick WR; Coco BJ; Sadkowski LC; Fothergill AW; Waite A; Rinaldi MG; Patterson TF; Thomas CR
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):79-83. PubMed ID: 12909218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
    J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in
    Chen M; Cheng T; Xu C; Pan M; Wu J; Wang T; Wu D; Yan G; Wang C; Shao J
    Virulence; 2022 Dec; 13(1):428-443. PubMed ID: 35195502
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
    Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
    J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1997; 40 Suppl 1():53-5. PubMed ID: 9417514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.
    Heald AE; Cox GM; Schell WA; Bartlett JA; Perfect JR
    AIDS; 1996 Mar; 10(3):263-8. PubMed ID: 8882665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
    Oude Lashof AM; De Bock R; Herbrecht R; de Pauw BE; Krcmery V; Aoun M; Akova M; Cohen J; Siffnerová H; Egyed M; Ellis M; Marinus A; Sylvester R; Kullberg BJ;
    Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.